500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
The purpose of this research study is to show whether the Neo system is safe and works in
people with heart failure.
Ages:21 and older
Inclusion Criteria: - Age 21 years or above. - On optimal, guideline-directed (per the American Heart Association/American College of Cardiology guidelines), stable, heart-failure medications and dose for at least 4 weeks prior to screening. Exclusion Criteria: - Known or suspected baroreflex failure or autonomic neuropathy. - Myocardial infarction, unstable angina, syncope, cerebral vascular accident, sudden cardiac death (SCD), or received defibrillation therapy within 3 months. - Heart failure secondary to a reversible cause or treatable condition.
Sponsor: CVRx, Inc.
Trial ID: NCT01720160
Not Accepting Healthy Volunteers